What is Bayer’s contribution to safety research?
Nanotechnology is one of the key technologies of the 21st century. Nanomaterials are being used increasingly in many different spheres of our lives, and for this reason their safe use must be ensured by way of detailed, accompanying research into the potential related risks. After all, the economic success of nanomaterials depends to a great extent on the acceptance of nanotechnology in society. In addition to its innovative activities, Bayer for many years now has been researching safety in the field of nanotechnology . We want to help gather and document fundamental knowledge on this subject. In line with our Responsible Care principles, we commit ourselves to ensure the safety of our products. A key aspect of nanomaterial safety is the improvement not only of measurable methods required to characterize nanomaterials and determine workplace exposure, but also of toxicological test methods (in-vitro and in-vivo). The NanoCare and TRACER projects funded by the BMBF – to which Bayer is
